IL-1ra和RSAD2在老年肺炎反应中的意义

    Significance of IL-1ra and RSAD2 in pneumonia reaction in the elderly

    • 摘要:
      目的: 探讨白细胞介素(IL)-1受体拮抗剂(IL-1ra)和含S自由基的腺苷甲硫氨酸域蛋白2(RSAD2)在肺炎反应中的意义。
      方法: 选取50例CAP住院病人作为CAP组,根据2007年美国传染病学会/美国胸科学会成人CAP管理指南分为重症CAP组14例和非重症CAP组36例;选择同期18名健康体检者作为对照组。使用Bio-Plex Pro人细胞因子筛选板测量细胞因子水平。Spearman等级相关法分析血浆细胞因子表达水平和CURB-65评分之间的相关性。通过ROC曲线下面积(AUC)分析血浆细胞因子水平预测重症CAP病人的价值。
      结果: 重症CAP病人年龄、住院时间、CURB-65评分均高于非重症CAP病人(P < 0.05~P < 0.01)。入院时,重症CAP组和非重症CAP组IL-1β、IL-1ra、IL-6、IL-13、IL-18、肝细胞生长因子(HGF)、RSAD2、干扰素-γ诱导单核细胞因子(MIG)、巨噬细胞集落刺激因子(M-CSF)、巨噬细胞炎症蛋白1β和干扰素γ诱导蛋白10(IP-10)水平均高于对照组(P < 0.05),重症CAP组IP-10、IL-1ra和M-CSF水平均高于非重症CAP组(P < 0.05);病程第3天和病程第7天,重症CAP组的IP-10、HGF、MIG和RSAD2水平高于非重症CAP组(P < 0.05);病程第3天,重症CAP组IL-18水平高于非重症CAP组(P < 0.05);病程第7天,重症CAP组IL-13水平低于非重症CAP组(P < 0.05),IL-1β水平高于非重症CAP组(P < 0.05)。ROC曲线分析显示,AUC前3的细胞因子分别为IL-1ra(0.930)、IP-10(0.866)、RSAD2(0.803);IL-1ra与RSAD2组合的AUC为0.990,IP-10与IL-1ra组合的AUC为0.976,RSAD2与IP-10组合的AUC为0.857,3种细胞因子的组合的AUC为0.990。Spearman等级相关分析显示,入院时,IP-10、RSAD2、HGF、MIG和IL-1ra表达水平与CURB-65评分均呈明显正相关关系(rs = 0.651、0.580、0.632、0.513、0.473,P < 0.01)。
      结论: IL-1ra和RSAD2与CAP疾病严重程度高度相关,可以作为重症CAP的良好预测因子。因此,检测CAP早期病人IL-1ra和RSAD2的表达水平,可为制定具体的治疗策略提供有用的信息。

       

      Abstract:
      Objective To explore the significance of IL (interleukin)-1 receptor antagonist (IL-1ra) and radical S-adenosyl methionine domain-containing protein 2 (RSAD2) in pneumonia reaction.
      Methods Fifty hospitalized patients with CAP were selected as the CAP group, and divided into a severe CAP group (n = 14) and a non-severe CAP group (n = 36) according to the 2007 adult CAP management guidelines of the Infectious Diseases Society of America/American Thoracic Society. Eighteen health examinees during the same period were selected as the control group. The levels of cytokine were measured using Bio-Plex Pro human cytokine screening plate. Spearman rank correlation method was used to analyze the correlation between the expression levels of plasma cytokine and CURB-65 scores. The prediction value of plasma cytokine levels in severe CAP patients was analyzed by the area under the ROC curve (AUC).
      Results The age, length of hospital stay, and CURB-65 score of severe CAP patients were higher than those of non-severe CAP patients (P < 0.05 to P < 0.01). At admission, the levels of IL-1β, IL-1ra, IL-6, IL-13, IL-18, hepatocyte growth factor (HGF), RSAD2, monokine induced by interferon-γ (MIG), macrophage colony-stimulating factor (M-CSF), macrophage inflammatory protein 1β, and interferon-γ inducible protein 10 (IP-10) in the severe CAP group and non-severe CAP group were higher than those in the control group (P < 0.05), and the levels of IP-10, IL-1ra, and M-CSF in the severe CAP group were higher than those in the non-severe CAP group (P < 0.05); on the third and seventh day of the disease course, the levels of IP-10, HGF, MIG, and RSAD2 in the severe CAP group were higher than those in the non-severe CAP patients (P < 0.05); on the third day of the disease course, the IL-18 level in the severe CAP group was higher than that in the non-severe CAP group (P < 0.05); on the seventh day of the disease course, the IL-13 level in the severe CAP group was lower than that in the non-severe CAP group (P < 0.05), and the IL-1β level was higher than that in the non-severe CAP group (P < 0.05). ROC curve analysis showed that the top three cytokines in AUC were IL-1ra (0.930), IP-10 (0.866), and RSAD2 (0.803); the AUC of the combination of IL-1ra and RSAD2 was 0.990, AUC of the combination of IP-10 and IL-1ra eas 0.976, AUC of the combination of RSAD2 and IP-10 was 0.857, and AUC of the combination of three cytokines was 0.990. Spearman rank correlation analysis showed that at admission, the expression levels of IP-10, RSAD2, HGF, MIG, and IL-1ra were significantly positively correlated with CURB-65 scores (rs = 0.651, 0.580, 0.632, 0.513, 0.473, P < 0.01).
      Conclusions IL-1ra and RSAD2 are highly correlated with the severity of CAP, and can be used as good predictors of severe CAP. Therefore, detecting the expression levels of IL-1ra and RSAD2 in patients with early CAP can provide useful information for formulating specific treatment strategies.

       

    /

    返回文章
    返回